BioLargo, Inc. (BLGO)

OTCMKTS · Delayed Price · Currency is USD

0.1661

-0.0059 (-3.43%)

Mar 6, 2026, 3:29 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
ONM Environmental		15.60M	11.44M	4.37M	1.42M	1.57M
ONM Environmental Growth		36.34%	161.55%	208.25%	-9.50%	7.47%
BLEST		3.20M	2.40M	1.94M	1.64M	1.05M
BLEST Growth		33.38%	23.37%	18.84%	55.71%	5.11%
BioLargo Canada		72.00K	30.00K	1,000.00	12.00K	37.00K
BioLargo Canada Growth		140.00%	2900.00%	-91.67%	-67.57%	-
Intersegment Revenue		-1.09M	-1.66M	-495.00K	-681.00K	-477.00K
BioLargo Corporate		-	-	5.00K	7.00K	14.00K
BioLargo Corporate Growth		-	-	-28.57%	-50.00%	-
Clyra Medical		-	20.00K	56.00K	139.00K	240.00K
Clyra Medical Growth		-	-64.29%	-59.71%	-42.08%	-
Total		17.78M	12.23M	5.88M	2.53M	2.43M
Total Growth		45.37%	107.85%	132.48%	4.07%	30.68%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States		17.78M	12.23M	5.88M	2.53M	2.43M
United States Growth		45.37%	107.85%	132.48%	4.07%	30.68%
Total		17.78M	12.23M	5.88M	2.53M	2.43M
Total Growth		45.37%	107.85%	132.48%	4.07%	30.68%

Source: S&P Global Market Intelligence.